Ciclopirox Olamine Market - Global Outlook and Forecast 2021-2027

April 2021 | 103 pages | ID: CC29DCD3AB8EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Ciclopirox Olamine in Global, including the following market information:

Global Ciclopirox Olamine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Ciclopirox Olamine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ciclopirox Olamine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ciclopirox Olamine Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Ciclopirox Olamine Market Segment Percentages, By Type, 2020 (%)

• Cream Preparation
• Temperture
• Vaginal Suppository

China Ciclopirox Olamine Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Ciclopirox Olamine Market Segment Percentages, By Application, 2020 (%)

• Ringworm Of The Body
• Athlete'S Foot
• Tinea
• Tinea Versicolor
• Candida Albicans
• Gynecological Anti-Infection Preparation
• Other

Global Ciclopirox Olamine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Ciclopirox Olamine Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Ciclopirox Olamine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Ciclopirox Olamine Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Bayer
• Apotex Corporation
• Fougera (Sandoz)
• Medimetriks Pharmaceuticals
• Taro Pharmaceuticals
• Preferred Pharmaceuticals
• Ingenus Pharmaceuticals
• Alvogen (CVC Capital Partners and Temasek )
• Acella Pharmaceuticals
• Dr Marc's Manufacturing
• Paddock Laboratories (Perrigo)
• Sincerus
• Glades Pharmaceuticals (GSK)
• Sterimax
• Guangzhou Kanghe Pharmaceutical
• Tianjin Lisheng Pharmaceutical
• Zhejiang Xianju Pharmaceutical
• Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ciclopirox Olamine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ciclopirox Olamine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CICLOPIROX OLAMINE OVERALL MARKET SIZE

2.1 Global Ciclopirox Olamine Market Size: 2021 VS 2027
2.2 Global Ciclopirox Olamine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ciclopirox Olamine Players in Global Market
3.2 Top Global Ciclopirox Olamine Companies Ranked by Revenue
3.3 Global Ciclopirox Olamine Revenue by Companies
3.4 Top 3 and Top 5 Ciclopirox Olamine Companies in Global Market, by Revenue in 2020
3.5 Global Companies Ciclopirox Olamine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ciclopirox Olamine Players in Global Market
  3.6.1 List of Global Tier 1 Ciclopirox Olamine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ciclopirox Olamine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Ciclopirox Olamine Market Size Markets, 2021 & 2027
  4.1.2 Cream Preparation
  4.1.3 Temperture
  4.1.4 Vaginal Suppository
4.2 By Type - Global Ciclopirox Olamine Revenue & Forecasts
  4.2.1 By Type - Global Ciclopirox Olamine Revenue, 2016-2021
  4.2.2 By Type - Global Ciclopirox Olamine Revenue, 2022-2027
  4.2.3 By Type - Global Ciclopirox Olamine Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ciclopirox Olamine Market Size, 2021 & 2027
  5.1.2 Ringworm Of The Body
  5.1.3 Athlete'S Foot
  5.1.4 Tinea
  5.1.5 Tinea Versicolor
  5.1.6 Candida Albicans
  5.1.7 Gynecological Anti-Infection Preparation
  5.1.8 Other
5.2 By Application - Global Ciclopirox Olamine Revenue & Forecasts
  5.2.1 By Application - Global Ciclopirox Olamine Revenue, 2016-2021
  5.2.2 By Application - Global Ciclopirox Olamine Revenue, 2022-2027
  5.2.3 By Application - Global Ciclopirox Olamine Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Ciclopirox Olamine Market Size, 2021 & 2027
6.2 By Region - Global Ciclopirox Olamine Revenue & Forecasts
  6.2.1 By Region - Global Ciclopirox Olamine Revenue, 2016-2021
  6.2.2 By Region - Global Ciclopirox Olamine Revenue, 2022-2027
  6.2.3 By Region - Global Ciclopirox Olamine Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Ciclopirox Olamine Revenue, 2016-2027
  6.3.2 US Ciclopirox Olamine Market Size, 2016-2027
  6.3.3 Canada Ciclopirox Olamine Market Size, 2016-2027
  6.3.4 Mexico Ciclopirox Olamine Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Ciclopirox Olamine Revenue, 2016-2027
  6.4.2 Germany Ciclopirox Olamine Market Size, 2016-2027
  6.4.3 France Ciclopirox Olamine Market Size, 2016-2027
  6.4.4 U.K. Ciclopirox Olamine Market Size, 2016-2027
  6.4.5 Italy Ciclopirox Olamine Market Size, 2016-2027
  6.4.6 Russia Ciclopirox Olamine Market Size, 2016-2027
  6.4.7 Nordic Countries Ciclopirox Olamine Market Size, 2016-2027
  6.4.8 Benelux Ciclopirox Olamine Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Ciclopirox Olamine Revenue, 2016-2027
  6.5.2 China Ciclopirox Olamine Market Size, 2016-2027
  6.5.3 Japan Ciclopirox Olamine Market Size, 2016-2027
  6.5.4 South Korea Ciclopirox Olamine Market Size, 2016-2027
  6.5.5 Southeast Asia Ciclopirox Olamine Market Size, 2016-2027
  6.5.6 India Ciclopirox Olamine Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Ciclopirox Olamine Revenue, 2016-2027
  6.6.2 Brazil Ciclopirox Olamine Market Size, 2016-2027
  6.6.3 Argentina Ciclopirox Olamine Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ciclopirox Olamine Revenue, 2016-2027
  6.7.2 Turkey Ciclopirox Olamine Market Size, 2016-2027
  6.7.3 Israel Ciclopirox Olamine Market Size, 2016-2027
  6.7.4 Saudi Arabia Ciclopirox Olamine Market Size, 2016-2027
  6.7.5 UAE Ciclopirox Olamine Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Ciclopirox Olamine Major Product Offerings
  7.1.4 Bayer Ciclopirox Olamine Revenue in Global (2016-2021)
  7.1.5 Bayer Key News
7.2 Apotex Corporation
  7.2.1 Apotex Corporation Corporate Summary
  7.2.2 Apotex Corporation Business Overview
  7.2.3 Apotex Corporation Ciclopirox Olamine Major Product Offerings
  7.2.4 Apotex Corporation Ciclopirox Olamine Revenue in Global (2016-2021)
  7.2.5 Apotex Corporation Key News
7.3 Fougera (Sandoz)
  7.3.1 Fougera (Sandoz) Corporate Summary
  7.3.2 Fougera (Sandoz) Business Overview
  7.3.3 Fougera (Sandoz) Ciclopirox Olamine Major Product Offerings
  7.3.4 Fougera (Sandoz) Ciclopirox Olamine Revenue in Global (2016-2021)
  7.3.5 Fougera (Sandoz) Key News
7.4 Medimetriks Pharmaceuticals
  7.4.1 Medimetriks Pharmaceuticals Corporate Summary
  7.4.2 Medimetriks Pharmaceuticals Business Overview
  7.4.3 Medimetriks Pharmaceuticals Ciclopirox Olamine Major Product Offerings
  7.4.4 Medimetriks Pharmaceuticals Ciclopirox Olamine Revenue in Global (2016-2021)
  7.4.5 Medimetriks Pharmaceuticals Key News
7.5 Taro Pharmaceuticals
  7.5.1 Taro Pharmaceuticals Corporate Summary
  7.5.2 Taro Pharmaceuticals Business Overview
  7.5.3 Taro Pharmaceuticals Ciclopirox Olamine Major Product Offerings
  7.5.4 Taro Pharmaceuticals Ciclopirox Olamine Revenue in Global (2016-2021)
  7.5.5 Taro Pharmaceuticals Key News
7.6 Preferred Pharmaceuticals
  7.6.1 Preferred Pharmaceuticals Corporate Summary
  7.6.2 Preferred Pharmaceuticals Business Overview
  7.6.3 Preferred Pharmaceuticals Ciclopirox Olamine Major Product Offerings
  7.6.4 Preferred Pharmaceuticals Ciclopirox Olamine Revenue in Global (2016-2021)
  7.6.5 Preferred Pharmaceuticals Key News
7.7 Ingenus Pharmaceuticals
  7.7.1 Ingenus Pharmaceuticals Corporate Summary
  7.7.2 Ingenus Pharmaceuticals Business Overview
  7.7.3 Ingenus Pharmaceuticals Ciclopirox Olamine Major Product Offerings
  7.4.4 Ingenus Pharmaceuticals Ciclopirox Olamine Revenue in Global (2016-2021)
  7.7.5 Ingenus Pharmaceuticals Key News
7.8 Alvogen (CVC Capital Partners and Temasek )
  7.8.1 Alvogen (CVC Capital Partners and Temasek ) Corporate Summary
  7.8.2 Alvogen (CVC Capital Partners and Temasek ) Business Overview
  7.8.3 Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Major Product Offerings
  7.8.4 Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Revenue in Global (2016-2021)
  7.8.5 Alvogen (CVC Capital Partners and Temasek ) Key News
7.9 Acella Pharmaceuticals
  7.9.1 Acella Pharmaceuticals Corporate Summary
  7.9.2 Acella Pharmaceuticals Business Overview
  7.9.3 Acella Pharmaceuticals Ciclopirox Olamine Major Product Offerings
  7.9.4 Acella Pharmaceuticals Ciclopirox Olamine Revenue in Global (2016-2021)
  7.9.5 Acella Pharmaceuticals Key News
7.10 Dr Marc's Manufacturing
  7.10.1 Dr Marc's Manufacturing Corporate Summary
  7.10.2 Dr Marc's Manufacturing Business Overview
  7.10.3 Dr Marc's Manufacturing Ciclopirox Olamine Major Product Offerings
  7.10.4 Dr Marc's Manufacturing Ciclopirox Olamine Revenue in Global (2016-2021)
  7.10.5 Dr Marc's Manufacturing Key News
7.11 Paddock Laboratories (Perrigo)
  7.11.1 Paddock Laboratories (Perrigo) Corporate Summary
  7.11.2 Paddock Laboratories (Perrigo) Business Overview
  7.11.3 Paddock Laboratories (Perrigo) Ciclopirox Olamine Major Product Offerings
  7.11.4 Paddock Laboratories (Perrigo) Ciclopirox Olamine Revenue in Global (2016-2021)
  7.11.5 Paddock Laboratories (Perrigo) Key News
7.12 Sincerus
  7.12.1 Sincerus Corporate Summary
  7.12.2 Sincerus Business Overview
  7.12.3 Sincerus Ciclopirox Olamine Major Product Offerings
  7.12.4 Sincerus Ciclopirox Olamine Revenue in Global (2016-2021)
  7.12.5 Sincerus Key News
7.13 Glades Pharmaceuticals (GSK)
  7.13.1 Glades Pharmaceuticals (GSK) Corporate Summary
  7.13.2 Glades Pharmaceuticals (GSK) Business Overview
  7.13.3 Glades Pharmaceuticals (GSK) Ciclopirox Olamine Major Product Offerings
  7.13.4 Glades Pharmaceuticals (GSK) Ciclopirox Olamine Revenue in Global (2016-2021)
  7.13.5 Glades Pharmaceuticals (GSK) Key News
7.14 Sterimax
  7.14.1 Sterimax Corporate Summary
  7.14.2 Sterimax Business Overview
  7.14.3 Sterimax Ciclopirox Olamine Major Product Offerings
  7.14.4 Sterimax Ciclopirox Olamine Revenue in Global (2016-2021)
  7.14.5 Sterimax Key News
7.15 Guangzhou Kanghe Pharmaceutical
  7.15.1 Guangzhou Kanghe Pharmaceutical Corporate Summary
  7.15.2 Guangzhou Kanghe Pharmaceutical Business Overview
  7.15.3 Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Major Product Offerings
  7.15.4 Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Revenue in Global (2016-2021)
  7.15.5 Guangzhou Kanghe Pharmaceutical Key News
7.16 Tianjin Lisheng Pharmaceutical
  7.16.1 Tianjin Lisheng Pharmaceutical Corporate Summary
  7.16.2 Tianjin Lisheng Pharmaceutical Business Overview
  7.16.3 Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Major Product Offerings
  7.16.4 Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Revenue in Global (2016-2021)
  7.16.5 Tianjin Lisheng Pharmaceutical Key News
7.17 Zhejiang Xianju Pharmaceutical
  7.17.1 Zhejiang Xianju Pharmaceutical Corporate Summary
  7.17.2 Zhejiang Xianju Pharmaceutical Business Overview
  7.17.3 Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Major Product Offerings
  7.17.4 Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Revenue in Global (2016-2021)
  7.17.5 Zhejiang Xianju Pharmaceutical Key News
7.18 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
  7.18.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Summary
  7.18.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
  7.18.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Major Product Offerings
  7.18.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Revenue in Global (2016-2021)
  7.18.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ciclopirox Olamine Market Opportunities & Trends in Global Market
Table 2. Ciclopirox Olamine Market Drivers in Global Market
Table 3. Ciclopirox Olamine Market Restraints in Global Market
Table 4. Key Players of Ciclopirox Olamine in Global Market
Table 5. Top Ciclopirox Olamine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Ciclopirox Olamine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Ciclopirox Olamine Revenue Share by Companies, 2016-2021
Table 8. Global Companies Ciclopirox Olamine Product Type
Table 9. List of Global Tier 1 Ciclopirox Olamine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ciclopirox Olamine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Ciclopirox Olamine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Ciclopirox Olamine Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Ciclopirox Olamine Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Ciclopirox Olamine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Ciclopirox Olamine Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Ciclopirox Olamine Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Ciclopirox Olamine Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Ciclopirox Olamine Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Ciclopirox Olamine Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Ciclopirox Olamine Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Ciclopirox Olamine Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Ciclopirox Olamine Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Ciclopirox Olamine Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Ciclopirox Olamine Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Ciclopirox Olamine Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Ciclopirox Olamine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Ciclopirox Olamine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Ciclopirox Olamine Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Ciclopirox Olamine Revenue, (US$, Mn), 2022-2027
Table 30. Bayer Corporate Summary
Table 31. Bayer Ciclopirox Olamine Product Offerings
Table 32. Bayer Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 33. Apotex Corporation Corporate Summary
Table 34. Apotex Corporation Ciclopirox Olamine Product Offerings
Table 35. Apotex Corporation Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 36. Fougera (Sandoz) Corporate Summary
Table 37. Fougera (Sandoz) Ciclopirox Olamine Product Offerings
Table 38. Fougera (Sandoz) Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 39. Medimetriks Pharmaceuticals Corporate Summary
Table 40. Medimetriks Pharmaceuticals Ciclopirox Olamine Product Offerings
Table 41. Medimetriks Pharmaceuticals Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 42. Taro Pharmaceuticals Corporate Summary
Table 43. Taro Pharmaceuticals Ciclopirox Olamine Product Offerings
Table 44. Taro Pharmaceuticals Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 45. Preferred Pharmaceuticals Corporate Summary
Table 46. Preferred Pharmaceuticals Ciclopirox Olamine Product Offerings
Table 47. Preferred Pharmaceuticals Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 48. Ingenus Pharmaceuticals Corporate Summary
Table 49. Ingenus Pharmaceuticals Ciclopirox Olamine Product Offerings
Table 50. Ingenus Pharmaceuticals Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 51. Alvogen (CVC Capital Partners and Temasek ) Corporate Summary
Table 52. Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Product Offerings
Table 53. Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 54. Acella Pharmaceuticals Corporate Summary
Table 55. Acella Pharmaceuticals Ciclopirox Olamine Product Offerings
Table 56. Acella Pharmaceuticals Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 57. Dr Marc's Manufacturing Corporate Summary
Table 58. Dr Marc's Manufacturing Ciclopirox Olamine Product Offerings
Table 59. Dr Marc's Manufacturing Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 60. Paddock Laboratories (Perrigo) Corporate Summary
Table 61. Paddock Laboratories (Perrigo) Ciclopirox Olamine Product Offerings
Table 62. Paddock Laboratories (Perrigo) Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 63. Sincerus Corporate Summary
Table 64. Sincerus Ciclopirox Olamine Product Offerings
Table 65. Sincerus Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 66. Glades Pharmaceuticals (GSK) Corporate Summary
Table 67. Glades Pharmaceuticals (GSK) Ciclopirox Olamine Product Offerings
Table 68. Glades Pharmaceuticals (GSK) Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 69. Sterimax Corporate Summary
Table 70. Sterimax Ciclopirox Olamine Product Offerings
Table 71. Sterimax Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 72. Guangzhou Kanghe Pharmaceutical Corporate Summary
Table 73. Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Product Offerings
Table 74. Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 75. Tianjin Lisheng Pharmaceutical Corporate Summary
Table 76. Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Product Offerings
Table 77. Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 78. Zhejiang Xianju Pharmaceutical Corporate Summary
Table 79. Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Product Offerings
Table 80. Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)
Table 81. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Summary
Table 82. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Product Offerings
Table 83. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Ciclopirox Olamine Segment by Type
Figure 2. Ciclopirox Olamine Segment by Application
Figure 3. Global Ciclopirox Olamine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Ciclopirox Olamine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Ciclopirox Olamine Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ciclopirox Olamine Revenue in 2020
Figure 8. By Type - Global Ciclopirox Olamine Revenue Market Share, 2016-2027
Figure 9. By Application - Global Ciclopirox Olamine Revenue Market Share, 2016-2027
Figure 10. By Region - Global Ciclopirox Olamine Revenue Market Share, 2016-2027
Figure 11. By Country - North America Ciclopirox Olamine Revenue Market Share, 2016-2027
Figure 12. US Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Ciclopirox Olamine Revenue Market Share, 2016-2027
Figure 16. Germany Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 17. France Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Ciclopirox Olamine Revenue Market Share, 2016-2027
Figure 24. China Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 28. India Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Ciclopirox Olamine Revenue Market Share, 2016-2027
Figure 30. Brazil Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Ciclopirox Olamine Revenue Market Share, 2016-2027
Figure 33. Turkey Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Ciclopirox Olamine Revenue, (US$, Mn), 2016-2027
Figure 37. Bayer Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Apotex Corporation Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Fougera (Sandoz) Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Medimetriks Pharmaceuticals Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Taro Pharmaceuticals Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Preferred Pharmaceuticals Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Ingenus Pharmaceuticals Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Acella Pharmaceuticals Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Dr Marc's Manufacturing Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Paddock Laboratories (Perrigo) Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Sincerus Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Glades Pharmaceuticals (GSK) Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Sterimax Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)